Encare - Enhancing ERAS®

Encare - Enhancing ERAS®

IT-tjänster och IT-konsulttjänster

Stockholm, Stockholm County 2 238 följare

Our vision is to digitalize science to help save lives and improve quality of life.

Om oss

It is our vision to digitalize science to help save lives and improve quality of life. We are proud of the changes in healthcare that we have already helped bring about: • Improved recovery after surgery • Shorter hospitalization • Improved quality of life • And lives saved Encare was established in 2009 to develop and implement the ERAS® protocols globally. Since the foundation, we have developed an interactive, user-friendly interface, the ERAS® Interactive Audit System (EIAS), for collection, documentation and follow up on critical performance and quality parameters as outlined by leading clinical experts in respective ERAS® Protocols. The data collected in EIAS is interactive and offers immediate feedback generating significant and sustainable improvement of efficiency and quality of care as well as generate substantial cost savings. Encare has the rights to commercialize surgical protocols developed by the ERAS® Society. The ERAS® Society, a non-profit scientific organization, develops perioperative care protocols and improves postoperative recovery through research, education, auditing and the application of scientific, evidence-based best practice. ERAS® Society has published a wide range of peer-reviewed publications that establishes, changes and updates best practice.

Webbplats
https://encare.net/
Bransch
IT-tjänster och IT-konsulttjänster
Företagsstorlek
11–50 anställda
Huvudkontor
Stockholm, Stockholm County
Typ
Privatägt företag
Grundat
2009
Specialistområden
ERAS®, ERAS® Interactive Audit System (EIAS), ERAS® Implementation Program (EIP) och Enhanced Recovery After Surgery

Adresser

Anställda på Encare - Enhancing ERAS®

Uppdateringar

Anslutna sidor

Liknande sidor

Finansiering

Encare - Enhancing ERAS® 4 rundor totalt

Senaste finansieringsrunda

Anonym

1 606 037,00 US$

Se mer info på crunchbase